Area of research
Applied Microbiology and Biotechnology · Pharmacology
Research interest
Research interests include Antibiotic Use and Resistance, Antibiotics Pharmacokinetics and Efficacy, Neonatal and Maternal Infections, and Pharmaceutical studies and practices.
Kangaroo Care as an intervention in randomised controlled trials in neonatal intensive care.
Improving Registration and Dataflows Between Pediatric Oncology Clinics and the Childhood Cancer Registry of Switzerland: Protocol for SwissPedCancer Quality Assurance Study.
Long-term assessment of developmental outcomes of newborn babies with sepsis
Antimicrobial Stewardship
Antimicrobial Stewardship
Availability and Quality of Anthropometric Data in Swiss Children’s Hospitals: The SwissPedGrowth Project
Infektionsprävention
Infektionsprävention
All-cause mortality and infection-related outcomes of hospital-initiated kangaroo care versus conventional neonatal care for low-birthweight infants: a systematic review and meta-analysis
Sense and Nonsense of Bacterial Decolonization in Neonatal Care.
Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: systematic review and meta-analysis
Safety and efficacy of antiseptic cleansing to reduce vertical transmission of multi-drug resistant pathogens to neonates (NeoVT-AMR)
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Vaccine value profile for Klebsiella pneumoniae
Vaccine value profile for Klebsiella pneumoniae.
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.
Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial.
High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland.
Implementation of infection prevention and control for hospitalized neonates: A narrative review.
Historic methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collection.
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial.
Tackling inappropriate antibiotic use in low-and middle-income countries.
Electronic hand hygiene monitoring tools for implementation of optimal hand sanitizing adherence in neonatal intensive care.
Neonatal sepsis: a complex high-impact global health challenge urgently requiring prioritization.
Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland.
Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva - A Case Study.
Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland.
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children.